Skip to content
Recall Observatory FDA recall evidence

Drug product

Ropinirole hydrochloride tablets, USP 4 mg, 100-count bottle (NDC 0378-5504-01), Rx only, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A. Made in India

D-500-2013

April 22, 2013

Class II

Product summary

Firm
Mylan Pharmaceuticals Inc.
Event
Event 65008
Status
Terminated
Classification
Class II
Quantity
3,048 bottles
Official record key
drug-enforcement:D-500-2013

Official wording

Reason: Labeling: Label Error on Declared Strength- Unopened bottles of Ropinirole USP 3 mg tablets was found to be incorrectly labeled as Ropinirole USP 4 mg tablets..

Code information: Lot # ZRMB11004, Exp 09/13

Distribution pattern: Nationwide

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    Labeling: Label Error